An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1) ; volume:9 ; number:1 ; day:5 ; month:10 ; year:2023 ; pages:1-16 ; date:12.2023
Pilot and feasibility studies ; 9, Heft 1 (5.10.2023), 1-16, 12.2023
- Creator
-
Donegan, Carina Joy
Daldegan-Bueno, Dimitri
Sumner, Rachael
Menkes, David
Evans, William
Hoeh, Nicholas
Sundram, Frederick
Reynolds, Lisa
Ponton, Rhys
Cavadino, Alana
Smith, Todd
Roop, Partha
Allen, Nathan
Abeysinghe, Binu
Svirskis, Darren
Forsyth, Anna
Bansal, Mahima
Muthukumaraswamy, Suresh
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40814-023-01399-8
- URN
-
urn:nbn:de:101:1-2024020512124968339977
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Donegan, Carina Joy
- Daldegan-Bueno, Dimitri
- Sumner, Rachael
- Menkes, David
- Evans, William
- Hoeh, Nicholas
- Sundram, Frederick
- Reynolds, Lisa
- Ponton, Rhys
- Cavadino, Alana
- Smith, Todd
- Roop, Partha
- Allen, Nathan
- Abeysinghe, Binu
- Svirskis, Darren
- Forsyth, Anna
- Bansal, Mahima
- Muthukumaraswamy, Suresh
- SpringerLink (Online service)
Other Objects (12)
Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study
Duloxetine in the treatment of major depressive disorder: an open-label study
Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial
An Open-Label Tolerability and Actual-Use Human Factors Study of Etrolizumab Autoinjector in Healthy Volunteers
Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
An Open-Label Investigation of the Pharmacokinetics and Tolerability of Oral Cysteamine in Adults with Cystic Fibrosis
Pharmacokinetics and tolerability of zibotentan (ZD4054) in subjects with hepatic or renal impairment: two open-label comparative studies
Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study
Safety and tolerability of oral vorolanib for neovascular (wet) age-related macular degeneration: a phase I, open-label study
Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)
Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study
Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study
Duloxetine in the treatment of major depressive disorder: an open-label study
Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial
An Open-Label Tolerability and Actual-Use Human Factors Study of Etrolizumab Autoinjector in Healthy Volunteers
Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
An Open-Label Investigation of the Pharmacokinetics and Tolerability of Oral Cysteamine in Adults with Cystic Fibrosis
Pharmacokinetics and tolerability of zibotentan (ZD4054) in subjects with hepatic or renal impairment: two open-label comparative studies
Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study
Safety and tolerability of oral vorolanib for neovascular (wet) age-related macular degeneration: a phase I, open-label study
Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)
Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study
Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study
Duloxetine in the treatment of major depressive disorder: an open-label study
Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial
An Open-Label Tolerability and Actual-Use Human Factors Study of Etrolizumab Autoinjector in Healthy Volunteers
Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
An Open-Label Investigation of the Pharmacokinetics and Tolerability of Oral Cysteamine in Adults with Cystic Fibrosis
Pharmacokinetics and tolerability of zibotentan (ZD4054) in subjects with hepatic or renal impairment: two open-label comparative studies
Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study
Safety and tolerability of oral vorolanib for neovascular (wet) age-related macular degeneration: a phase I, open-label study
Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)